EWA
ACHV icon

EverSource Wealth Advisors’s Achieve Life Sciences ACHV Stock Holding History

EverSource Wealth Advisors’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-26
Closed -$92 – 4013
2024
Q4 		$92 Buy
+26
New +$118 ﹤0.01% 3561

Other funds holding ACHV

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

EverSource Wealth Advisors's ACHV Position: Q1 2025 in Review

EverSource Wealth Advisors sold out of Achieve Life Sciences (ACHV) in Q1 2025, closing a stake of 26 shares — an estimated $92 sold.

EverSource Wealth Advisors first reported a position in ACHV in Q4 2024 and held it in 1 quarter. The position peaked at $92 in Q4 2024. 72 funds tracked by Wall St. Rank hold ACHV as of Q1 2025.

  • EverSource Wealth Advisors reported no remaining Achieve Life Sciences position as of Q1 2025 after selling out during the quarter.
  • EverSource Wealth Advisors sold 26 Achieve Life Sciences shares in Q1 2025, an estimated $92.
  • EverSource Wealth Advisors first reported a position in Achieve Life Sciences in Q4 2024 and held it in 1 quarter.
  • EverSource Wealth Advisors's Achieve Life Sciences position peaked at $92 in Q4 2024.
  • 72 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2025.

Based on EverSource Wealth Advisors's 13F filing for Q1 2025, filed 13 May 2025.